This medication is taken by injection.
Glatopa™ is the generic equivalent of Copaxone (glatiramer acetate) 20mg. The U.S. Food and Drug Administration (FDA) has approved Glatopa as substitutable for Copaxone 20mg; it is not substitutable for Copaxone 40mg.
Glatiramer acetate is a synthetic protein that simulates myelin basic protein, a component of the myelin that insulates nerve fibers in the brain and spinal cord. This drug seems to block myelin-damaging T-cells through a mechanism that is not completely understood.
Glatopa is approved by the U.S. Food and Drug Administration (FDA) to reduce the frequency of relapses in patients with relapsing-remitting MS. It is also approved for use in individuals who have experienced a first clinical episode (clinically-isolated syndrome) and have MRI features that are consistent with multiple sclerosis.
Click here to read the FDA Prescribing Information for healthcare professionals. To read the Patient Information for Glatopa, go to Prescribing Information and scroll down to p. 14.
GLATOPA SUPPORT PROGRAM
Financial Assistance Program